After finalizing the Helomics sale, Axe Compute completely transitioned its business focus to a GPU-as-a-Service model. Fueled by numerous high-value GPU compute contracts, the organization has experienced a remarkably fast evolution, shifting from a small oncology research firm into a Nasdaq-listed neocloud platform.

The pace of this growth is clearly reflected in their recent financial agreements. The enterprise advanced from a $260 million contract in April to securing more than $3 billion in signed contract value for 2026 by late July.

We invite you to read our new blog to discover more about the order book, company milestones, and the underlying build model driving @AxeCompute.